Breaking News Instant updates and real-time market news.

TWTR

Twitter

$19.85

-0.02 (-0.10%)

, CRM

Salesforce

$70.91

-0.35 (-0.49%)

16:26
10/07/16
10/07
16:26
10/07/16
16:26

On The Fly: Stocks end week lower after U.S. jobs report, U.K. pound flash crash

Stocks ended the week lower after a "flash crash" in the British pound fueled Brexit worries, or vice versa, and a weaker than expected jobs report did not sway expectations for an interest rate hike before the end of the year. MACRO NEWS: In the U.S., nonfarm payrolls increased 156,000 in September, below the 172,000 median forecast of economists. The unemployment rate rose to 5% from 4.9%, where it had been forecast to remain. Construction spending declined 0.7% in August. The ISM manufacturing index bounced 2.1 points to 51.5 in September. Markit's manufacturing index fell to 51.5 for the final September print. The U.S. trade deficit rose to $40.7B in August. Markit's services PMI climbed to 52.3 in the final September print. The ISM non-manufacturing index surged to 57.1 in September. Factory orders edged up 0.2% in August... In Europe, Markit's manufacturing PMI for the Eurozone rose to 52.6 in September. German industrial production rose 2.5% in August, while U.K. industrial production fell by 0.4%. The British pound plunged more than 6% in early Friday trading, sending the currency to a new 31-year low. The "flash crash" had traders baffled, as some pointed to a potential trader error and others blamed the price action on Brexit fears and remarks from French President Francois Hollande calling for tough Brexit talks... In Asia, China's official manufacturing PMI remained unchanged at 50.4 while Japan's manufacturing PMI edged up 0.1 points to 50.4 in September... The International Monetary Fund trimmed its forecast for U.S. growth this year by 0.6% and next year by 0.3%. For the global economy, the IMF made no changes to its forecast of 3.1% growth this year and 3.4% growth in 2017. COMPANY NEWS: Twitter (TWTR) made headlines all week after The Wall Street Journal said the company was expected to field takeover offers this week. Source told the publication Salesforce (CRM) was among the bidders, and that Alphabet and Disney (DIS) were also weighing a bid. However, a day after that report, Recode said Disney, Alphabet and Apple (AAPL) would likely not purchase the microblog service operator... Wal-Mart (WMT) tempered its profit forecast for the next two fiscal years due to investments in its online business and said store openings would slow... Shares of Booz Allen Hamilton (BAH) dropped following media reports saying the FBI arrested an NSA contractor, who worked for the company, and is looking into whether he stole and disclosed classified computer codes. This is second incident of its sort involving a Booz Allen employee, following the case of the now-infamous Edward Snowden... Alphabet's Google (GOOG, GOOGL) unveiled plans for new smartphones, dubbed the "Pixel" and "Pixel XL." The phone will be the first with Google Assistant built in, features improved Google Cloud storage functionality, and also sports an industry-leading camera. Pixel and its XL version will be available exclusively in the U.S. from Verizon (VZ) or from the Google Store. Google also showcased its Daydream View, a VR headset covered in fabric, the new 4K Chromecast Ultra, its modular Wi-Fi router system, and Google Home, the AI-powered speaker aimed at competing with Amazon's (AMZN) Echo... Tesla (TSLA) gave its quarterly update on global vehicle shipments, reporting a 70% rise in third quarter deliveries alongside a 37% growth in production, leading it to reaffirm its outlook for 50,000 deliveries in the second half of 2016... Ford (F), General Motors (GM) and Fiat Chrysler (FCAU) reported sales declines during the month of September, while Toyota Motor (TM) and Nissan (NSANY) posted higher U.S. September sales... Shares of TASER (TASR) dropped after the New York City Police Department awarded an over $6M contract for body cameras to the company's rival Vievu... Honeywell (HON) reported preliminary third-quarter profit below its prior forecast and cut the top end of the 2016 earnings target as sales slump for aircraft parts. KBR (KBR) sharply lowered its earnings per share guidance, citing increased costs to complete engineering, procurement and construction projects. PPG Industries (PPG) also cut its 2016 fiscal third quarter guidance... Zumiez (ZUMZ) and Gap (GPS) said September same-store sales grew 6.3% and 4%, respectively, sending shares of both retailers higher... In M&A news, Cabelas (CAB) agreed to be acquired by Bass Pro Shops for $65.50 per share in cash. Janus Capital (JNS) agreed to an all-stock merger of equals with Henderson Group. Endurance Specialty (ENH) agreed to be acquired by Japan's Sompo Holdings for $93 per share in cash. ICU Medical (ICUI) and Pfizer (PFE) announced that they have entered into a definitive agreement under which the former will acquire all of Pfizer's global infusion therapy business, Hospira Infusion Systems, for $1B in cash and stock. Under the terms of the agreement, Pfizer will receive about $400M in newly issued shares of ICU Medical, resulting in Pfizer owning approximately 16.6% of ICU upon completion of the deal... Among companies that announced quarterly results this week, Darden Restaurants (DRI), Constellation Brands (STZ) and Monsanto (MON) advanced following their reports, while Micron Technology (MU), AZZ (AZZ), AngioDynamics (ANGO), and Yum! Brands (YUM) declined. INDEXES: For the week, the Dow fell 0.38% to 18,240.49, the Nasdaq lost 0.38% to 5,292.40, and the S&P 500 declined 0.67% to 2,153.74.

TWTR

Twitter

$19.85

-0.02 (-0.10%)

CRM

Salesforce

$70.91

-0.35 (-0.49%)

DIS

Disney

$92.49

-0.34 (-0.37%)

WMT

Wal-Mart

$68.70

-0.66 (-0.95%)

AAPL

Apple

$114.06

0.17 (0.15%)

GOOG

Alphabet

$775.08

-1.78 (-0.23%)

GOOGL

Alphabet Class A

$800.71

-2.37 (-0.30%)

AMZN

Amazon.com

$839.43

-2.23 (-0.26%)

TSLA

Tesla

$196.61

-4.39 (-2.18%)

F

Ford

$12.29

-0.1 (-0.81%)

GM

General Motors

$32.34

-0.19 (-0.58%)

FCAU

Fiat Chrysler

$6.47

-0.05 (-0.77%)

TM

Toyota

$115.89

-0.55 (-0.47%)

NSANY

Nissan

$19.53

-0.07 (-0.36%)

TASR

TASER

$22.43

-0.87 (-3.73%)

KBR

KBR

$16.14

-0.04 (-0.25%)

BAH

Booz Allen

$30.19

-0.89 (-2.86%)

ZUMZ

Zumiez

$21.93

0.78 (3.69%)

GPS

Gap

$26.25

3.47 (15.23%)

PPG

PPG Industries

$93.73

-8.46 (-8.28%)

CAB

Cabela's

$62.25

-0.9 (-1.43%)

JNS

Janus Capital

$14.39

-0.09 (-0.62%)

ENH

Endurance Specialty

$91.75

0.2 (0.22%)

ICUI

ICU Medical

$149.65

4.97 (3.44%)

PFE

Pfizer

$33.56

-0.09 (-0.27%)

DRI

Darden

$61.63

0.68 (1.12%)

STZ

Constellation Brands

$168.84

-2.19 (-1.28%)

MON

Monsanto

$103.36

-0.14 (-0.14%)

MU

Micron

$17.61

-0.12 (-0.68%)

AZZ

AZZ Inc.

$55.82

-2.49 (-4.27%)

ANGO

AngioDynamics

$16.58

0.055 (0.33%)

YUM

Yum! Brands

$87.72

0.28 (0.32%)

HON

Honeywell

$106.94

-8.67 (-7.50%)

  • 07

    Oct

  • 11

    Oct

  • 12

    Oct

  • 18

    Oct

  • 20

    Oct

  • 21

    Oct

  • 23

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 27

    Oct

  • 01

    Nov

  • 01

    Nov

  • 02

    Nov

  • 02

    Nov

  • 02

    Nov

  • 09

    Nov

  • 10

    Nov

  • 10

    Nov

  • 17

    Nov

  • 30

    Nov

  • 15

    Jan

  • 13

    Mar

TWTR Twitter
$19.85

-0.02 (-0.10%)

10/07/16
PIPR
10/07/16
NO CHANGE
Target $100
PIPR
Overweight
Piper sees 'clouds parting' on Salesforce valuation
Salesforce CEO Marc Benioff mostly calmed nerves over a potential Twitter (TWTR) acquisition by saying at the company's analyst day, "While we look at everything, we pass on almost everything," Piper Jaffray analyst Alex Zukin tells investors in a research note. The comment does not completely take a deal for Twitter off the table, but the probability of a transformational acquisition is now "dramatically lower," Zukin contends. As such, the analyst feels the "clouds are parting" on Salesforce's valuation "with sunshine ahead." Zukin believes the company has a "clear line of sight" to $10B in revenue in FY17. He keeps an Overweight rating on the shares with a $100 price target. Salesforce closed yesterday up $2.84, or 4%, to $71.26.
10/07/16
ADAM
10/07/16
NO CHANGE
Target $95
ADAM
Buy
Salesforce worthy of investor consideration at current levels, says Canaccord
Canaccord analyst Richard Davis came away from the Salesforce (CRM) Dreamforce week more enthused about the company's outlook. The analyst noted the company is growing its revenues 3.5 times faster than it legacy peers. Davis noted the company's CEO said they are very disciplined on price when it comes to acquisitions and believes that they would not be interested in Twitter (TWTR) at its rumored asking price of $28 per share. Davis reiterated his Buy rating and $95 price target on Salesforce shares.
10/06/16
BMOC
10/06/16
NO CHANGE
BMOC
Twitter acquisition would hurt Salesforce, says BMO Capital
BMO Capital analyst Keith Bachman says that an acquisition of Twitter (TWTR) by Salesforce (CRM) would " offer little strategic fit, would slow revenue growth and would be dilutive to (free cash flow) margins." Bachman thinks that the deal would cause Salesforce's stock to drop significantly,. and he says that the company's stock would be worth $65 if it pulls the trigger on Twitter. The analyst says that Salesforce's current valuation is attractive if it does not buy Twitter. He keeps an $86 price target and Outperform rating on Salesforce.
10/06/16
COWN
10/06/16
NO CHANGE
Target $100
COWN
Outperform
Salesforce shares should rebound with no Twitter deal, says Cowen
Cowen analyst J.Derrick Wood expects shares of Salesforce (CRM) to rebound if the company does not buy Twitter (TWTR), which he believes will not happen. The analyst believes investors will return to fundamentals and the analyst believes upside momentum in Salesforce's core business will return in Q3. Wood reiterated his Outperform rating and $100 price target on Salesforce shares.
CRM Salesforce
$70.91

-0.35 (-0.49%)

DIS Disney
$92.49

-0.34 (-0.37%)

09/26/16
09/26/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Disney (DIS) downgraded to Hold from Buy at Drexel Hamilton with analyst Tony Wible saying he believes a large step up in NBA costs, incremental subscribers losses, difficult studio comps, a riskier studio slate, and Shanghai cost pressures will weigh on fiscal 2017. 2. Twitter (TWTR) downgraded to Underperform from Perform at Oppenheimer with analyst Jason Helfstein saying a media company is the most likely acquirer of Twitter and would not pay meaningfully more than the valuation implied by our price target. 3. RetailMeNot (SALE) downgraded to Sell from Hold at Stifel with analyst Scott Devitt saying third party data indicates that the company's traffic trends have deteriorated recently. 4. Finish Line (FINL) downgraded to Neutral from Buy at Buckingham with the firm's analyst believing shares will be range bound in medium term due to high comp expectations, cost savings will be offset by incentive compensation and other investments, and less compelling valuation. 5. NetApp (NTAP) downgraded to Sell from Hold at Deutsche Bank with analyst Sherri Scribner saying secular challenges in the storage market are not reflected in NetApp's current valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/27/16
SBSH
09/27/16
NO CHANGE
Target $16
SBSH
Neutral
Citi sees 40% downside in Twitter with no takeover bid
Citi analyst Mark May believes Twitter's (TWTR) risk/reward skews to the downside following the recent rally in the shares. A buyout of the company carries "strategic rationale for certain companies," but Twitter's "struggles and steep valuation" make a deal at a meaningful premium less likely, May tells investors in a research note. A takeover at $26 per share looks aggressive, May contends. He believes the stock could retest the lows of late May, representing 40% downside from current levels, should an acquisition offer not materialize. The analyst keeps a Neutral rating on Twitter with a $16 price target. The shares closed yesterday up 75c to $23.37 following reports that Disney (DIS) may be joining the list of potential acquires that already includes Alphabet (GOOG) and Salesforce (CRM).
09/28/16
SBSH
09/28/16
NO CHANGE
SBSH
Buy
Citi hopes Disney does not acquire Twitter
Citi analyst Jason Bazinet lays out four reasons for why he doesn't like Disney (DIS) pursuing an acquisition of Twitter (TWTR). Going back 15 years, the analyst can't think of a single web-based property that was successfully acquired by a traditional media firm. Two, he calls Twitter trends "troubling." Three, Bazinet estimates a cash offer would lower Disney's stock by $5 per share while an equity offer would drop its stock by $9. Four, the analyst feels it is unclear how Disney's content will help Twitter. Bazinet thinks both Yahoo (YHOO) and Twitter lost "significant money" when they streamed NFL content over the web. The analyst hopes Twitter is acquired by somebody other than Disney. He keeps a Buy rating on Disney shares. Both Loop Capital and Mizuho this morning downgraded Twitter to sell ratings.
10/06/16
SBSH
10/06/16
NO CHANGE
Target $89
SBSH
Buy
Citi says Salesforce buying Twitter 'nearly impossible' above $28/share
Citi analyst Walter Pritchard believes a Salesforce (CRM) acquisition of Twitter (TWTR) is possible financially but that such a deal would put "significant constraints" on the company for the next three-plus years. The analyst sees "very little reason" for Salesforce to own Twitter and feels the acquisition "would pose a difficult decision" for CEO Marc Benioff and the board. Salesforce closed yesterday down 6%, or $4.21, to $68.42. Recode reported last night that the company is likely the only bidder left for Twitter after Disney (DIS) and Alphabet (GOOG) opted not to pursue a deal while Apple (AAPL) is unlikely. Twitter in pre-market trading is down 14% to $21.50. In order for Salesforce to avoid a shareholder vote, it would have to borrow $7.5B to fund the transaction if Twitter were valued at $20B, or $27.50-$28 per share, Pritchard tells investors in a research note. This is a level that likely constrains the company with little additional borrowing capacity for other deals, the analyst contends. He thinks the deal is "nearly impossible to do" for Salesforce should the bidding for Twitter go above $20B or $28 per share. Pritchard has a Buy rating on Salesforce with an $89 price target.
WMT Wal-Mart
$68.70

-0.66 (-0.95%)

10/07/16
BARD
10/07/16
NO CHANGE
Target $80
BARD
Outperform
Wal-Mart moving into next phase of transformation, says Baird
Baird analyst Peter Benedict said the Wal-Mart analyst meeting highlighted the next phase of the company's transformation. The analyst believes the convergence of initiatives will help sustain the company's current momentum, which is seeing traction across many aspects of its business. Benedict believes the strategy is the right one for the business and investors over the long-term. Benedict maintained his Outperform rating and $80 price target on Wal-Mart shares.
09/30/16
09/30/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Amazon.com (AMZN) initiated with a Buy at Guggenheim. 2. Wal-Mart (WMT) initiated with an Overweight at KeyBanc and a Buy at Guggenheim. 3. Harley-Davidson (HOG) initiated with a Hold at Jefferies. 4. Coach (COH) was initiated with a Buy at Guggenheim while the firm initiated Michael Kors (KORS) with a Neutral. 5. First Solar (FSLR) initiated with a Buy at Williams Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/30/16
GUGG
09/30/16
INITIATION
Target $82
GUGG
Buy
Wal-Mart initiated with a Buy at Guggenheim
Guggenheim analyst Robert Drbul initiated Wal-Mart with a Buy and a $82 price target saying it is successfully adapting to the rapidly changing consumer environment and remains laser focused on improving its critical U.S. supercenter business.
09/29/16
KEYB
09/29/16
INITIATION
Target $90
KEYB
Overweight
Wal-Mart initiated with an Overweight, momentum building, says KeyBanc
As previously reported, KeyBanc initiated Wal-Mart with an Overweight and a $90 price target. Analyst Edward Yruma believes Wal-Mart's investments in e-commerce and technology will drive sustainable market share gains and return the company to both consistent revenue and EBITDA growth in 2017.
AAPL Apple
$114.06

0.17 (0.15%)

10/07/16
RBCM
10/07/16
NO CHANGE
RBCM
Apple average selling prices could beat expectations, says RBC Capital
RBC Capital analyst Amit Daryanani says that his analysis indicates that the average selling prices of Apple's iPhone 7 could significantly exceed Street expectations. Stronger demand for the "plus" model versus the last two years, along with the fact that Apple is charging a $120 premium for the "plus" model versus a $100 premium historically, should boost average selling prices, the analyst stated. He thinks that Apple's September quarter revenue could beat expectations by a "modest" amount, while the company's December quarter guidance could be "materially ahead of Street expectations." He keeps a $125 price target and Outperform rating on the stock.
10/06/16
ADAM
10/06/16
NO CHANGE
Target $140
ADAM
Buy
Apple iPhone 7 demand remains healthy, says Canaccord
Canaccord analyst T. Michael Walkley said channel checks show demand for iPhone 7 remains healthy with an ongoing strong mix leading to higher selling prices. The analyst believes the iPhone 6 and iPhone 6s products enabled Apple to materially increase its market share and installed base of the premium tier smartphone market. Walkley reiterate his Buy rating and $140 price target on Apple shares.
10/06/16
RBCM
10/06/16
NO CHANGE
RBCM
Apple has positive read through from Dialog results, says RBC Capital
After Dialog issued a positive preannouncement due to higher than expected Mobile Services revenue, RBC Capital analyst Amit Daryanani thinks that the Dialog results should comfort Apple investors heading into that company's September quarter results. The analyst notes that Apple accounts for 75%-80% of Dialog's revenue. He keeps a $125 price target and Outperform rating on Apple.
GOOG Alphabet
$775.08

-1.78 (-0.23%)

09/28/16
09/28/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Alphabet (GOOG, GOOGL) downgraded to Underperform from Neutral at Wedbush with analyst James Dix citing concerns that the "Four Horsemen of the Search Apocalypse" -- self-identified consumers, consumer control of IP-delivered ads, payments innovation, and attention markets -- might arrive. 2. AT&T (T) downgraded to Neutral from Buy at UBS with analyst John Hodulik citing expectations for lower earnings growth. 3. Macy's (M) downgraded to Neutral from Outperform at Credit Suisse with analyst Michael Exstein saying the retailer, after outlining in August its operations and merchandising strategies, is now in an execution phase. 4. Twitter (TWTR) downgraded to Underperform from Neutral at Mizuho and to Sell from Hold at Loop Capital. 5. Galectin Therapeutics (GALT) downgraded to Sell from Buy at Roth Capital with analyst Sa'ar Yaniv citing the company's announcement that NASH-FX, GR-MD-02's Phase 2a study in NASH fibrosis, failed both primary and secondary endpoints. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/28/16
MZHO
09/28/16
DOWNGRADE
Target $15
MZHO
Underperform
Mizuho cuts Twitter to Underperform with $15 price target
Mizuho analyst Neil Doshi downgraded Twitter to Underperform from Neutral based on valuation. The shares are up 45% since the company reported Q2 results, primarily driven by potential buyout comments in media reports, Doshi tells investors in a research note. The stock at current levels is overvalued as Twitter's business fundamentals "have deteriorated significantly" over the past 12 months, the analyst contends. Doshi believes many of the M&A scenarios are unlikely to play out. He puts potential acquirers Salesforce (CRM) and Alphabet (GOOG, GOOGL) in the "maybe" camp, but he still has some reservations about these deals happening. The analyst believes investors of both companies would view a buyout of Twitter as negative. Doshi keeps a $15 price target for Twitter shares. The stock closed yesterday up 35c to $23.72. Loop Capital this morning also downgraded Twitter to Sell.
09/27/16
WEDB
09/27/16
DOWNGRADE
WEDB
Underperform
Alphabet downgraded to Underperform from Neutral at Wedbush
Wedbush analyst James Dix downgraded Alphabet to Underperform and lowered his price target on shares to $700 on concerns the "Four Horsemen of the Search Apocalypse" -- self-identified consumers, consumer control of IP-delivered ads, payments innovation, and attention markets -- might arrive.
GOOGL Alphabet Class A
$800.71

-2.37 (-0.30%)

09/30/16
RBCM
09/30/16
NO CHANGE
RBCM
Street underestimating Google growth outlook, says RBC Capital
RBC Capital analyst Mark Mahaney expects Google to end 2016 with "up to 20% growth," versus the Street's outlook of mid teen percentage level growth. Mahaney says that Google's growth should be boosted by "ongoing Search innovations, rising Mobile CPCs, and the growing impact of YouTube, Play & Cloud." He thinks that YouTube's revenue is growing at a 30%-40% clip. Mahaney raised his price target on the stock to $1,025 from $1,000 and keeps an Outperform rating on the shares.
AMZN Amazon.com
$839.43

-2.23 (-0.26%)

10/05/16
MSCO
10/05/16
NO CHANGE
Target $950
MSCO
Overweight
Amazon.com price target raised to $950 from $800 at Morgan Stanley
Morgan Stanley analyst Brian Nowak raised Amazon.com's price target to $950 from $800 to reflect the continued ramp in Prime subscribers. The analyst said Amazon's Prime subscribers are now at 60M members and he expects Prime subscriber spending to be approximately 4.5X that of non-Prime users. Nowak raised his 2017 CSOI estimate by 4% to $530M to reflect a larger gross profit pool that more than offsets higher streaming content costs and a large expected fulfillment build in 2017. The analyst recommends buying Amazon on any investor sentiment swings due to potential below Street Q1 2017 guidance in January and maintains his Overweight rating.
10/05/16
MKMP
10/05/16
NO CHANGE
MKMP
Buy
Reported VMware pact with Amazon a positive, says MKM Partners
MKM Partners analyst Kevin Buttigieg noted the Fortune report claiming that VMware (VMW) will soon announce a cloud partnership with Amazon Web Services (AMZN). Such an agreement with Amazon would be positive for VMware, as it will signal their confidence in their ability to sell software for use on-premise and underscore a belief that public cloud is unlikely to assume all workloads. The firm has a Buy rating on VMware shares.
10/05/16
RHCO
10/05/16
NO CHANGE
Target $850
RHCO
Neutral
Amazon.com price target raised to $850 from $800 at SunTrust
SunTrust analyst Robert Peck continues to think Amazon will benefit from the Prime flywheel, higher third-party adoption, and secular Web Services growth, but he keeps a Neutral rating on the stock, citing the positive assumptions already "baked into" Street expectations, rising competition, its high capital intensity and tough comps. The analyst raised his price target on Amazon shares to $850 from $800.
10/06/16
OPCO
10/06/16
NO CHANGE
OPCO
Microsoft, Amazon well positioned to enable cloud, AI trends, says Oppenheimer
Oppenheimer analyst Timothy Horan notes that machine learning and artificial intelligence have been use to improve applications and acceleration of infrastructure builds, with "intelligent software" designed to make lives easier and more productive. Further, the analyst sees communications and cloud services continuing to converge, with infrastructure and data as key components to AI. Microsoft (MSFT) and Amazon (AMZN) Web Service are well positioned to enable these trends, he contends, adding that he see colocation providers, such as Equinix (EQIX) and Interxion (INXN), and networking companies like Zayo Group (ZAYO) GTT Communications (GTT) as beneficiaries.
TSLA Tesla
$196.61

-4.39 (-2.18%)

10/06/16
GSCO
10/06/16
DOWNGRADE
GSCO
Neutral
Tesla downgraded to Neutral from Buy at Goldman
Goldman analyst David Tamberrino downgraded Tesla to Neutral and lowered his price target to $185 from $240. Tamberrino sees incremental risk to Tesla's business related to management's willingness to deploy capital for M&A, and he believes that any delay in the company's new Model 3 launch will be detrimental to shares. The analyst said there is room for downward estimate revisions as volume ramps slower and spending grows. Tamberrino's 2016 earnigns estimate of (59c) is above the Street's (93c), but estimates for 2017 through 2019 are on average 48% below consensus.
10/06/16
GSCO
10/06/16
NO CHANGE
GSCO
Autos and Autos Parts sector downgraded to Cautious from Neutral at Goldman
Goldman analyst David Tamberrino downgraded the Autos and Auto Parts sector to Cautious from Neutral saying the US Auto cycle peaked in 2015 and is being held up by increasing OEM incentives. The analyst said OEM earnings will decline in 2017/2018 as negative pricing and lower production pressure North American results, but expects suppliers' earnings to hold up longer. The analyst sees upside to Delphi (DLPH) and Harman (HAR) given exposure to secular growth areas and upside to Goodyear Tire (GT) given secular HVA tire growth. Tamberrino downgraded Lear (LEA) to Sell citing elevated expectations and valuation, cut BorgWarner (BWA) to Neutral on valuation, downgraded Tesla (TSLA) to Neutral on execution risk and capital deployment, and upgraded AutoNation (AN) to Neutral given a more defensive business.
10/06/16
10/06/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Tesla (TSLA) downgraded to Neutral from Buy at Goldman with analyst David Tamberrino saying he sees incremental risk to Tesla's business related to management's willingness to deploy capital for M&A, and he believes that any delay in the company's new Model 3 launch will be detrimental to shares. 2. JPMorgan (JPM) downgraded to Hold from Buy at Sandler O'Neill with analyst Jeffery Harte citing relative share outperformance. 3. Abercrombie & Fitch (ANF) downgraded to Sector Weight from Overweight at KeyBanc with analyst Jessica Schmidt saying the elevated promotions add to other headwinds, including the fact that the teen space is "overstored" and faces soft consumer demand and weak tourism. 4. American Express (AXP) downgraded to Reduce from Neutral at Nomura with analyst Bill Carcache saying the combination of weaker than expected revenues and higher than expected expenses will weigh on the shares. 5. Lowe's (LOW) downgraded to Neutral from Buy at Cleveland Research. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/03/16
OPCO
10/03/16
NO CHANGE
OPCO
Perform
Review process of SolarCity acquisition may be delayed, says Oppenheimer
Oppenheimer analyst Colin Rusch believes the SEC review process of Tesla's (TSLA) acquisition of SolarCity (SCTY) could be delayed due to recent activity, especially new litigation. Further, the analyst believes extension to the timeline is likely to work against the deal given the risk of ongoing "collaboration to trigger gun-jumping rules." Rusch reiterates a Perform rating on Tesla's shares.
F Ford
$12.29

-0.1 (-0.81%)

09/29/16
LOOP
09/29/16
NO CHANGE
Target $115
LOOP
Buy
Loop Capital wonders if Trump is trying to kill Kansas City Southern
Following Monday's presidential debate, Loop Capital analyst Rick Paterson is rethinking his reluctance to believing a potential Donald Trump presidency is a threat to Kansas City Southern's business. Trump opened the debate by attacking Kansas City Southern customer Ford Motor's (F) transplanting of auto assembly plants from the U.S. to Mexico, Paterson tells investors in a research note. KSU was the best performing rail stock and the Mexican peso was 2.5% stronger the day after Hillary Clinton's debate victory, the analyst points out. He views Mexico as a "key growth engine" for both KSU and Union Pacific (UNP). Paterson cites a CNN poll for Clinton's debate victory. The analyst has a Buy rating on KSU with a $115 price target.
09/20/16
09/20/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Ford (F) downgraded to Neutral from Buy at Buckingham with analyst Joseph Amaturo saying he believes North American volume and pricing trends for trucks will deteriorate and is concerned that the passenger car market will remain challenged given stiff competition from Japanese and European OEMs that can heavily discount due to weak currencies. 2. General Mills (GIS) downgraded to Underperform from Neutral at Consumer Edge. 3. Ascena Retail (ASNA) downgraded to Sector Perform from Outperform at RBC Capital and to Perform from Outperform at Oppenheimer. 4. Avnet (AVT) downgraded to Hold from Buy at Stifel and to Sell from Hold at Cross Research. 5. HD Supply (HDS) downgraded to Sector Perform from Outperform at RBC Capital with analyst Deane Dray saying it will take several quarters for the company to address its supply chain errors, and she expects the stock "to stay range bound over the medium term." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/20/16
09/20/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Ford (F) initiated with a Buy at Nomura. 2. Intel (INTC) was initiated with a Positive at Susquehanna while the firm initiated AMD (AMD) with a Neutral. 3. HSN, Inc. (HSNI) initiated with an Underperform at BofA/Merrill. 4. Bojangles (BOJA) initiated with a Strong Buy at CL King. 5. D.R. Horton (DHI) initiated with an Outperform at Wedbush. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
GM General Motors
$32.34

-0.19 (-0.58%)

09/19/16
09/19/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. General Motors (GM) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Adam Jonas saying he believes even flat earnings in 2017 and 2018 would be received as a positive surprise by the market. 2. Wells Fargo (WFC) upgraded to Outperform from Neutral at Baird analyst David George saying he believes the recent pullback is a buying opportunity. 3. Lockheed Martin (LMT) upgraded to Outperform from Market Perform at Wells Fargo with analyst Sam Pearlstein saying he believes the company's earnings can grow 20% per year through 2020. 4. U.S. Steel (X), AK Steel (AKS), and Olympic Steel (ZEUS) were upgraded to Sector Weight from Underweight at KeyBanc with analyst Ivan Marcuse saying the stocks at current levels better reflect the more competitive market conditions he expects in Q4 and 2017. 5. Mattel (MAT) upgraded to Buy from Neutral at Monness Crespi. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/19/16
09/19/16
UPGRADE
Target $37

Overweight
General Motors upgraded to Overweight at Morgan Stanley
As previously reported, Morgan Stanley upgraded General Motors to Overweight from Equal Weight and increased its price target to $37 from $29. Analyst Adam Jonas raised near-term earnings estimates 5% above consensus and believes even flat earnings in 2017 and 2018 would be received as a positive surprise by the market. Further, the analyst said investors are underestimating how long the auto cycle can last and that General Motor's earnings and free cash flow could have a materially longer duration than the market is currently discounting. He believes investors are overlooking the time and steps needed for fully autonomous transport and said management has a healthy and realistic acceptance that it can't and should not do everything alone and will likely explore new business structures with the potential of positive values.
09/20/16
NOMU
09/20/16
INITIATION
Target $33
NOMU
Neutral
General Motors initiated with a Neutral at Nomura
Nomura analyst Anindya Das initiated General Motors with a Neutral and a $33 price target. The analyst said General Motors has significant exposure to the Chinese auto market and is concerned about pricing pressures in the market. Further, the company has yet to break even in Europe on an annual basis and its near-term prospects are clouded by Brexit uncertainties.
FCAU Fiat Chrysler
$6.47

-0.05 (-0.77%)

08/09/16
JEFF
08/09/16
INITIATION
Target $8.25
JEFF
Buy
Fiat Chrysler initiated with a Buy at Jefferies
Jefferies analyst Philippe Houchois started Fiat Chrysler with a Buy rating and $8.25 price target.
07/06/16
07/06/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Netflix (NFLX) downgraded to Underperform from Hold at Jefferies with analyst John Janedis saying Netflix's domestic subscriber growth trajectory "may be somewhat flatter" than the market's current expectations. 2. American Airlines (AAL) downgraded to Underperform from Outperform at Credit Suisse with analyst Jule Yates downgrading the airline two notches citing high leverage, weaker free cash flow, and a lofty valuation. 3. AB InBev (BUD) downgraded to Underperform from Sector Perform at RBC Capital with analyst James Edwardes Jones saying he expects normal synergies from the SABMiller (SBMRY) deal but said it will not materially alter AB InBev's volume concentration and lacks additional upside. 4. Fiat Chrysler (FCAU) downgraded to Underweight from Overweight at Barclays with analyst Kristina Church downgrading the stock two notches saying, the company's "highly levered" balance sheet makes it "too risky to own." 5. United Continental (UAL) downgraded to Neutral from Outperform at Credit Suisse with analyst Jule Yates citing challenging revenue growth heading into Q3. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/06/16
LEHM
07/06/16
DOWNGRADE
LEHM
Underweight
Fiat Chrysler downgraded to Underweight from Overweight at Barclays
Barclays analyst Kristina Church double downgraded Fiat Chrysler to Underweight from Overweight and cut her price target for the shares to EUR 5.5 from EUR 10. The company's "highly levered" balance sheet makes it "too risky to own," Church tells investors in a research note.
08/09/16
08/09/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Ford (F) initiated with an Underperform, General Motors (GM) initiated with a Hold, and Fiat Chrysler (FCAU) initiated with a Buy at Jefferies. Ford and General Motors were also initiated with a Buy at Seaport Global. 2. AMC Networks (AMCX) initiated with a Hold at Loop Capital. 3. Lionsgate (LGF) initiated with a Buy at Loop Capital. 4. Barrick Gold (ABX) initiated with an Equal Weight at Morgan Stanley. 5. AdvancePierre Foods (APFH) initiated with a Neutral at Goldman, an Outperform at BMO Capital, a Buy at Deutsche Bank, and an Outperform at Credit Suisse. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
TM Toyota
$115.89

-0.55 (-0.47%)

05/27/16
UBSW
05/27/16
DOWNGRADE
UBSW
Sell
Toyota downgraded to Sell from Neutral at UBS
09/05/16
GSCO
09/05/16
DOWNGRADE
GSCO
Neutral
Toyota downgraded to Neutral from Buy at Goldman
Goldman Sachs downgraded Toyota (TM) to Neutral and kept a Buy rating on Honda (HMC).
05/11/16
MZHO
05/11/16
DOWNGRADE
MZHO
Neutral
Toyota downgraded to Neutral from Buy at Mizuho
08/25/16
SBSH
08/25/16
DOWNGRADE
SBSH
Neutral
Toyota downgraded to Neutral from Buy at Citi
Citi analyst Arifumi Yoshida downgraded Toyota to Neutral citing recent yen strength versus European currencies that will negatively impact the premium Lexus segment.
NSANY Nissan
$19.53

-0.07 (-0.36%)

11/30/15
11/30/15
UPGRADE

On The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Atwood Oceanics (ATW) upgraded to Buy from Neutral at Guggenheim... C&J Energy (CJES) upgraded to Buy from Neutral at Guggenheim... CARBO Ceramics (CRR) upgraded to Buy from Neutral at Guggenheim... Cameron (CAM) upgraded to Buy from Neutral at Guggenheim... Core Laboratories (CLB) upgraded to Buy from Neutral at Guggenheim... Diamond Offshore (DO) upgraded to Buy from Neutral at Guggenheim... Dril-Quip (DRQ) upgraded to Buy from Neutral at Guggenheim... Ensco (ESV) upgraded to Buy from Neutral at Guggenheim... FMC Technologies (FTI) upgraded to Buy from Neutral at Guggenheim... Fitbit (FIT) upgraded to Overweight from Equal Weight at Barclays... Forum Energy (FET) upgraded to Buy from Neutral at Guggenheim... Frank's International (FI) upgraded to Buy from Neutral at Guggenheim... General Dynamics (GD) upgraded to Overweight from Equal Weight at Barclays... Heidrick & Struggles (HSII) upgraded to Outperform from Market Perform at Barrington... Helmerich & Payne (HP) upgraded to Buy from Neutral at Guggenheim... Huaneng Power (HNP) upgraded to Neutral from Sell at UBS... Microsoft (MSFT) upgraded to Strong Buy from Market Perform at Raymond James... Nabors Industries (NBR) upgraded to Buy from Neutral at Guggenheim... National Oilwell (NOV) upgraded to Buy from Neutral at Guggenheim... New York Community Bancorp (NYCB) upgraded to Buy from Neutral at BofA/Merrill... Nissan (NSANY) upgraded to Buy from Neutral at Citi... Noble Corp. (NE) upgraded to Buy from Neutral at Guggenheim... Oceaneering (OII) upgraded to Buy from Neutral at Guggenheim... Oil States (OIS) upgraded to Buy from Neutral at Guggenheim... PNM Resources (PNM) upgraded to Overweight from Equal Weight at Barclays... Pacific Drilling (PACD) upgraded to Buy from Neutral at Guggenheim... Parsley Energy (PE) upgraded to Focus List from Outperform at Scotia Howard Weil... Patterson-UTI (PTEN) upgraded to Buy from Neutral at Guggenheim... Philip Morris (PM) upgraded to Neutral from Reduce at Nomura... Rowan Companies (RDC) upgraded to Buy from Neutral at Guggenheim... Sage Group (SGPYY) upgraded to Buy from Hold at Canaccord... Seventy Seven Energy (SSE) upgraded to Buy from Neutral at Guggenheim... Superior Energy (SPN) upgraded to Buy from Neutral at Guggenheim... Synchrony (SYF) upgraded on expected technical factors at BMO Capital... Transocean (RIG) upgraded to Buy from Neutral at Guggenheim... Wright Medical (WMGI) upgraded to Buy from Hold at Jefferies... Zayo Group (ZAYO) upgraded to Outperform from Neutral at Macquarie.
08/16/16
JPMS
08/16/16
DOWNGRADE
JPMS
Neutral
Nissan downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Akira Kishimoto downgraded Nissan to Neutral on expectations model cycle deterioration in North America will have a large impact. The analyst also upgraded the Japan Auto sector to neutral from bearish.
10/05/16
UBSW
10/05/16
DOWNGRADE
UBSW
Neutral
Nissan downgraded to Neutral from Buy at UBS
11/30/15
SBSH
11/30/15
UPGRADE
SBSH
Buy
Nissan upgraded to Buy from Neutral at Citi
TASR TASER
$22.43

-0.87 (-3.73%)

10/06/16
JPMS
10/06/16
NO CHANGE
Target $31
JPMS
Overweight
NYPD contract fuels concerns, but TASER selloff overdone, says JPMorgan
JPMorgan analyst Mark Strouse notes that TASER's stock has declined significantly this week owing largely to the reported loss of the NYPD body-camera contract to a competitor. While the analyst sees this loss as somewhat of a surprise, he thinks the contract's pricing was the largest factor weighing on the stock. However, Strouse believes the NYPD contract pricing was a one-off occurrence. The analyst sees the selloff in TASER's shares as overdone and recommends investors add to positions. He reiterates an Overweight rating and $31 price target on the shares.
10/03/16
KING
10/03/16
NO CHANGE
Target $32
KING
Buy
TASER 'had no choice but to walk away' from NYPD deal, says CL King
CL King analyst George Godfrey said that according to a source he spoke with the $6.4M police body camera contract awarded by the City of New York may include cameras for as many as 5,000 police officers. If that is correct, TASER had "no choice but to walk away" from this opportunity, but the company still has the opportunity to sell body cameras to the other approximately 29,000 NYC police officers, Godfrey tells investors. The firm keeps a Buy rating and $32 price target on TASER shares, which are down about 14% to $24.62 in early afternoon trading.
10/05/16
OPCO
10/05/16
NO CHANGE
OPCO
Perform
TASER competitor deal with NYPD should not set any precedent, says Oppenheimer
Oppenheimer analyst Andrew Uerkwitz believes Vievu's body camera contract with NYPD could result in some pricing pressure over time but should not set any precedents. The analyst notes that it was expected that TASER "can't win them all," and points out that the economics of the deal are a "sober reminder" that storage costs are as key as service and functionality. Uerkwitz expects TASER to shift the conversation toward innovation, additional services/opportunities, and leverage going forward. He reiterates a Perform rating on TASER's shares.
10/06/16
JPMS
10/06/16
NO CHANGE
JPMS
Overweight
TASER selloff overdone, says JPMorgan
KBR KBR
$16.14

-0.04 (-0.25%)

10/04/16
DBAB
10/04/16
UPGRADE
Target $16
DBAB
Buy
KBR upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Chad Dillard upgraded KBR to Buy saying yesterday's 10% post-guidance cut selloff is overdone and backward-looking. The market is under-appreciating the company's transformation to a lower-risk government/technical services firm, Dillard tells investors in a research note. He upped his price target for KBR shares to $16 from $14.
10/05/16
JRCO
10/05/16
UPGRADE
Target $18
JRCO
Accumulate
KBR upgraded to Accumulate from Hold at Johnson Rice
Johnson Rice analyst Martin Malloy upgraded KBR to Accumulate with an $18 price target citing the recent pullback in shares and said the stock multiple should trend higher given the shift in business mix to more low-risk, cost reimbursement revenues.
10/05/16
10/05/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. UBS (UBS) upgraded to Sector Perform from Underperform at RBC Capital with analyst Fiona Swaffield saying she sees a dividend reduction as unlikely and believes expectations for the bank's Wealth Management business are now lower. 2. Parker-Hannifin (PH) upgraded to Buy from Hold at Stifel with analyst Nathan Jones saying distributors expect to see revenue growth declining 2% in the second quarter of fiscal 2017 which he believes should be enough for Parker to see its first positive year-over-year revenue comp company wide in six quarters. 3. Flex (FLEX) upgraded to Conviction Buy from Buy at Goldman with analyst Mark Delaney saying it is positioned to benefit from entry into new markets and valuation looks attractive. 4. KBR (KBR) upgraded to Accumulate from Hold at Johnson Rice with analyst Martin Malloy citing the recent pullback in shares and said the stock multiple should trend higher given the shift in business mix to more low-risk, cost reimbursement revenues. 5. Plains All American (PAA) upgraded to Outperform from Market Perform at Wells Fargo. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/04/16
10/04/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. CBS (CBS) upgraded to Buy from Sell at UBS with analyst Doug Mitchelson saying he sees any deal with Viacom (VIA) as priced into CBS shares already. He also has increased confidence in consensus estimates for CBS and sees further upside if the national TV ad market and CBS' ratings remain strong. 2. Pandora (P) upgraded to Conviction Buy from Buy at Goldman with analyst Heath Terry saying he sees significant upside to out-year estimates from premium radio and on-demand subscriptions. He expects competition to ease as new entrants slow and existing providers focus on profitability and limit "free" models. 3. Las Vegas Sands (LVS) upgraded to Buy from Neutral at BofA/Merrill with analyst Shaun Kelley saying shares remain fairly under-owned and thinks estimate revisions will move higher due to market momentum, better ROI for Parisian, Cotai infrastructure additions, and optionality from Japan and real estate. 4. KBR (KBR) upgraded to Buy from Hold at Deutsche Bank with analyst Chad Dillard saying yesterday's 10% post-guidance cut selloff is overdone and backward-looking. 5. West Marine (WMAR) upgraded to Buy from Neutral at B. Riley. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
BAH Booz Allen
$30.19

-0.89 (-2.86%)

10/06/16
10/06/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. AutoNation (AN) upgraded to Neutral from Sell at Goldman with analyst David Tamberrino saying valuation has bottomed and could be flat to slightly up in the near-term as SAAR bounces around the low-to-mid 17M range. 2. Trina Solar (TSL), Yingli Green Energy (YGE), and JA Solar (JASO) were upgraded to Buy from Sell at Axiom while the firm upgraded SolarCity (SCTY) to Hold from Sell. 3. PNC Financial (PNC) upgraded to Market Perform from Underperform at Raymond James with analyst David Long saying negative earnings revisions over the past two years have likely hit an inflection point. 4. Big 5 Sporting (BGFV) upgraded to Buy from Hold at Deutsche Bank with analyst Mike Baker citing accelerating sales trends and higher earnings power from profitability improvements. 5. Booz Allen (BAH) upgraded to Outperform from Market Perform at Raymond James with analyst Brian Gesuale saying the recent selloff creates an attractive entry point. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/06/16
RAJA
10/06/16
UPGRADE
Target $36
RAJA
Outperform
Booz Allen upgraded to Outperform from Market Perform at Raymond James
Raymond James analyst Brian Gesuale upgraded Booz Allen to Outperform and established a $36 price target saying yesterday's selloff creates an attractive entry point. The analyst said they do not expect an adverse impact to Booz Allen's NSA footprint following the latest employee controversy and notes it is only 5% of total revenue. Further, Gesuale said fundamentals are accelerating and earnings revision risk is to the upside.
04/12/16
04/12/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. AstraZeneca (AZN) downgraded to Sell at Goldman saying the risk/reward is negative due to valuation and high pipeline expectations. 2. Avon Products (AVP) downgraded to Neutral at Piper Jaffray by analyst Stephanie Wissink, who said Avon's topline growth now relies almost exclusively on international markets, where economic uncertainty persists. 3. Booz Allen (BAH) downgraded to Market Perform at Raymond James with analyst Brian Gesuale saying near-term consensus expectations are overly optimistic in terms of growth, despite management cautioning about needing time to staff recent contract wins and incremental investments required to drive long-term growth. 4. Hertz (HTZ) downgraded to Neutral at Credit Suisse by analyst Anjaneya Singh, who cited lower confidence in the company's outlook following yesterday's Q1 preannouncement. He adds that Hertz indicated that weaker pricing would cause revenue per available car day to decline 2.5%-3.5%. 5. L Brands (LB) downgraded to Neutral at Goldman with analyst Lindsay Drucker Mann saying last week's restructuring announcement will pressure Victoria's Secret near-term comp sales growth, which may result in multiple compression until visibility to comp re-acceleration improves. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/05/16
COWN
10/05/16
NO CHANGE
COWN
Outperform
Impact on Booz Allen from employee arrest unclear, says Cowen
Cowen analyst Cai von Rumohr said it is still unclear what impact the recent arrest of a Booz Allen employee alleged to have stolen classified computer codes while contracted at the NSA may have on the company. Since this incident is the second of its sort involving a Booz Allen employee, after Edward Snowden, it could have an impact on the company's brand image, the analyst said. However, von Rumohr noted that Booz Allen did not face any litigation, lose any contracts, or have any direct impact on its revenues in the wake of the Snowden incident and that its shares bounced back relatively quickly after the fall associated with that event. The firm keeps an Outperform rating on Booz Allen shares.
ZUMZ Zumiez
$21.93

0.78 (3.69%)

03/11/16
BMUR
03/11/16
NO CHANGE
Target $24
BMUR
Buy
Zumiez still best-in-class, says Brean Capital
Brean Capital noted Zumiez beat the firm's estimate for Q4 earnings but gave lower than expected guidance for Q1. The firm maintained its Buy rating on Zumiez, and as it considers it "best-in-class," citing its omni-channel investments that will start impacting the top line, easing comps and signs of a pickup in business. Brean Capital maintained its $24 price target on Zumiez shares.
10/06/16
RILY
10/06/16
UPGRADE
Target $25
RILY
Buy
Zumiez upgraded to Buy from Neutral at B. Riley
B. Riley analyst Jeff Van Sinderen upgraded Zumiez to Buy after the company reported better than expected September comps and upped its Q3 outlook. The analyst raised his price target for the shares to $25 from $18.
05/23/16
KEYB
05/23/16
NO CHANGE
KEYB
Some retailers better positioned than others to adopt to trends, says KeyBanc
After attending the Shoptalk conference, KeyBanc says that some retailers are better positioned than others to adopt to changing trends in the sector. Better positioned retailers include those "with compelling experiences," including Nordstrom (JWN), and those "with strong consumers connections," such as Lululemon (LULU), VF Corp (VFC), Oxford Industries (OXM), and Under Armour (UA), according to the firm. Conversely, retailers with large store footprints, particularly those with a significant presence in malls, "will continue to see pressure," KeyBanc believes. Among the companies in the latter category are L Brands (LB), Zumiez (ZUMZ), The Buckle (BKE), and Francesca's (FRAN), according to the firm.
10/06/16
WBLR
10/06/16
UPGRADE
WBLR
Outperform
Zumiez upgraded to Outperform from Market Perform at William Blair
William Blair analyst Sharon Zackfia upgraded Zumiez to Outperform saying September marked the company's best comp gain since February 2015. B. Riley this morning also upgraded Zumiez.
GPS Gap
$26.25

3.47 (15.23%)

10/07/16
DBAB
10/07/16
UPGRADE
Target $24
DBAB
Hold
Gap upgraded to Hold from Sell at Deutsche Bank
Deutsche Bank analyst Paul Trussell upgraded Gap to Hold saying the company's near- to medium-term setup is more favorable amid easing compares over the next few months and an improved apparel backdrop. Trussell raised his price target for the shares to $24 from $18.
10/07/16
UBSW
10/07/16
NO CHANGE
Target $16
UBSW
Sell
Gap distribution center fire impact not done being felt, says UBS
UBS analyst Michael Binetti noted Gap's distribution center fire in August had a significant impact on September sales and that the company estimates that the fire will be a 3 point drag to October same-store sales as well. Additionally, Binetti said Florida, Georgia and South Carolina account for 10% of the company's North America store count and that Gap will close some stores amid this weekend's hurricane, further impacting October sales. The company mentioned that merchant margins were higher than expected which should offset any negative earnings impact, however. The analyst is cautious of the company's ability to pull back on promotions to drive a comp inflection and reiterated his Sell rating and $16 price target on Gap shares.
10/07/16
JEFF
10/07/16
NO CHANGE
Target $32
JEFF
Buy
Jefferies sees 'sizable upside potential' in Gap shares
Jefferies analyst Randal Konik raises his price target for Gap shares to $32 from $30 following the retailer's September results. Trends are Old Navy are accelerating while a bottom setting in at The Gap, Konik tells investors in a research note. The analyst sees an "asymmetric risk/reward" for shares with downside "fairly limited" and "sizable upside potential." He sees easy comparisons as a near-term catalyst and keeps a Buy rating on the shares.
10/07/16
10/07/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Gap (GPS) upgraded to Hold from Sell at Deutsche Bank with analyst Paul Trussell saying the company's near-to medium-term setup is more favorable amid easing compares over the next few months and an improved apparel backdrop. 2. DuPont Fabros (DFT) upgraded to Buy from Hold at Stifel with analyst Matthew Heinz saying the company's current valuation reflects an expectation for weaker Q3 leasing activity. 3. Ralph Lauren (RL) upgraded to Conviction Buy from Buy at Goldman with analyst Lindsay Drucker Mann saying CEO Stefan Larsson's turnaround is firmly in place. 4. Restoration Hardware (RH) upgraded to Neutral from Underperform at Buckingham with the firm's analyst believing $1.60-$1.80 fiscal 2016 earnings are achievable, reducing the risk of further downward earnings revisions. 5. Vivint Solar (VSLR) upgraded to Neutral from Sell at Goldman with analyst Brian Lee saying the company is "moving on the path toward recovery." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
PPG PPG Industries
$93.73

-8.46 (-8.28%)

10/07/16
WELS
10/07/16
NO CHANGE
WELS
PPG Industries removed from Priority List at Wells Fargo
06/23/16
LBOW
06/23/16
UPGRADE
LBOW
Buy
PPG Industries upgraded to Buy from Neutral at Longbow
Longbow analyst Dmitry Silverstein upgraded PPG Industries to Buy with a $130 price target on shares. The analyst believes PPG's efforts to improve organic growth may be gaining momentum given evidence of accelerating growth in PPG's store channel and increased traction from new higher priced products at Menards. Further, faster growth of auto-OEM, Industrial, Aerospace and EMEA businesses in 2H16, driving above-consensus performance, upward earnings revisions and expanding multiples, the analyst wrote.
05/06/16
LYON
05/06/16
DOWNGRADE
LYON
Outperform
PPG Industries downgraded to Outperform from Buy at CLSA
07/26/16
GHSC
07/26/16
UPGRADE
Target $130
GHSC
Buy
PPG Industries upgraded to Buy from Accumulate at Seaport Global
Seaport Global analyst Michael Harrison upgraded PPG to Buy from Accumulate and raised its price target to $130 from $125. The analyst increased the outlook for the coatings business and adjusted the model to reflect the divestiture of most the Glass segment and said PPG is a high-quality core holding that should be able to leverage organic and inorganic growth opportunities, maintain focus on cost discipline, and return cash to shareholders.
CAB Cabela's
$62.25

-0.9 (-1.43%)

10/03/16
MKMP
10/03/16
DOWNGRADE
MKMP
Neutral
Cabela's downgraded to Neutral from Buy at MKM Partners
MKM Partners downgraded Cabela's to Hold following the acquisition by Bass Pro Shops for $65.50 per share.
07/06/16
DADA
07/06/16
NO CHANGE
DADA
Gun sales could continue to be strong through fall, says DA Davidson
Noting that firearm background checks jumped 28.6% year-over-year last month, DA Davidson attributes the surge to the Orlando terrorist attack and subsequent efforts to pass new gun control legislation. The firm thinks that continued pro-gun control rhetoric could create "a tailwind" for gun sales through the fall. DA Davidson says that Sportsman's Warehouse's (SPWH) valuation is attractive after the stock fell over 30% so far this year. It keeps a Buy rating on the shares. The firm keeps a Neutral rating on Cabela's (CAB). Smith & Wesson (SWHC) and Sturm, Ruger (RGR) manufacture guns.
10/03/16
FLTL
10/03/16
DOWNGRADE
FLTL
Hold
Cabela's downgraded to Hold from Buy at Feltl
Feltl downgraded Cabela's to Hold following the acquisition by Bass Pro Shops for $65.50 per share.
10/04/16
LEHM
10/04/16
DOWNGRADE
Target $64
LEHM
Equal Weight
Cabela's downgraded to Equal Weight from Overweight at Barclays
Barclays analyst Matthew McClintock downgraded Cabela's to Equal Weight saying the takeover offer from Bass Pro Shops fully values the company's assets. The analyst raised his price target for the shares to $64 from $50.
JNS Janus Capital
$14.39

-0.09 (-0.62%)

05/12/16
WELS
05/12/16
DOWNGRADE
WELS
Market Perform
Janus Capital downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo analyst Christopher Harris downgraded Janus Capital to Market Perform citing elevated risks given the company's concentrations in equity and growth. Some mean reversion with the markets near all-time highs and growth outperforming value for eight of the last nine years is likely to disproportionally hurt Janus, Harris tells investors in a research note. He lowered his price target range for the shares to $13-$15 from $16-$18.
10/04/16
JEFF
10/04/16
DOWNGRADE
Target $16
JEFF
Hold
Janus Capital downgraded to Hold from Buy at Jefferies
Jefferies analyst Daniel Fannon downgraded Janus Capital Group to Hold citing valuation following the company's announced merger with Henderson. The analyst views the proposed transaction positively from a strategic sense and keeps a $16 price target for the shares.
01/14/16
WELS
01/14/16
NO CHANGE
WELS
Janus Capital price target lowered to $13-$15 from $16-$18 at Wells Fargo
Wells Fargo cut its price target on Janus as the firm thinks the company's flows will be hurt by the 2016 equity market sell-off. The firm keeps an Outperform rating on the shares.
01/13/16
01/13/16
DOWNGRADE

On The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: American Express (AXP) downgraded to Neutral from Buy at Goldman... Ameriprise (AMP) downgraded to Market Perform from Outperform at Wells Fargo... Anchor BanCorp Wisconsin (ABCW) downgraded to Hold from Buy at Sandler O'Neill... ArcelorMittal (MT) downgraded to Underperform from Hold at Jefferies... Aspen Technology (AZPN) downgraded to Hold from Buy at Benchmark... BOK Financial (BOKF) downgraded to Underperform from Neutral at Macquarie... Bunzl (BZLFY) downgraded to Sell from Neutral at Goldman... CST Brands (CST) downgraded to Equal Weight from Overweight at Stephens... Charles Schwab (SCHW) downgraded to Neutral from Buy at BofA/Merrill... Church & Dwight (CHD) downgraded to Sell from Neutral at Goldman... Cimpress (CMPR) downgraded to Underweight from Equal Weight at Barclays... Conn's (CONN) downgraded on multiple headwinds at Stifel... Cullen/Frost (CFR) downgraded to Underweight from Equal Weight at Barclays... Dialog Semiconductor (DLGNF) downgraded to Underweight from Neutral at JPMorgan... Dover (DOV) downgraded to Sell from Neutral at UBS... Dr Pepper Snapple (DPS) downgraded to Sell from Neutral at Goldman... First American (FAF) downgraded to Sell from Neutral at Goldman... Goldcorp (GG) downgraded to Neutral from Outperform at Credit Suisse... Intelsat (I) downgraded to Sell from Neutral at Goldman... Janus Capital (JNS) downgraded to Neutral from Overweight at JPMorgan... LVMH (LVMUY) downgraded to Equal Weight from Overweight at Barclays... Landstar System (LSTR) downgraded to Market Perform from Outperform at William Blair... Lincoln National (LNC) downgraded to Market Perform from Outperform at Wells Fargo... Lloyds Banking (LYG) downgraded to Underperform from Neutral at Exane BNP Paribas... National Grid (NGG) downgraded to Sell from Neutral at UBS... PennyMac Financial (PFSI) downgraded to Neutral from Buy at Goldman... Plains All American (PAA) downgraded to Equalweight from Overweight at Capital One... Plains GP Holdings (PAGP) downgraded to Hold from Buy at Stifel... Roadrunner (RRTS) downgraded to Market Perform from Outperform at William Blair... Starwood Property (STWD) downgraded to Neutral from Buy at Goldman... TimkenSteel (TMST) downgraded to Hold from Buy at Jefferies... Ultra Petroleum (UPL) downgraded to Sell from Neutral at UBS... Under Armour (UA) downgraded to Mixed from Positive at OTR Global... Whiting Petroleum (WLL) downgraded to Neutral from Buy at UBS.
ENH Endurance Specialty
$91.75

0.2 (0.22%)

07/11/16
KBWI
07/11/16
UPGRADE
KBWI
Outperform
Endurance Specialty upgraded to Outperform at Keefe Bruyette
Keefe Bruyette upgraded Endurance Specialty Holdings to Outperform from Market Perform with a $79 price target on a transfer of coverage. The firm views the company's transformational story as compelling and highlights Endurance's recent margin improvement.
10/07/16
KBWI
10/07/16
DOWNGRADE
Target $93
KBWI
Market Perform
Endurance Specialty downgraded to Market Perform at Keefe Bruyette
Keefe Bruyette downgraded Endurance Specialty to Market Perform from Outperform citing the "attractive" takeover by Sompo. The analyst has a $93 price target for the shares.
ICUI ICU Medical
$149.65

4.97 (3.44%)

03/11/16
GABE
03/11/16
INITIATION
GABE
Buy
ICU Medical initiated with a Buy at Gabelli
01/14/16
PIPR
01/14/16
NO CHANGE
Target $129
PIPR
Overweight
Piper views potential Pfizer divestment as neutral for ICU Medical
Piper Jaffray analyst Thomas Gunderson views Bloomberg's report that Pfizer (PFE) may be considering a sale of the infusion pump division of the recently acquired Hospira as neutral for ICU Medical (ICUI). Hospira has traditionally been ICU's largest customer, which has some worrying that if the infusion pumps are sold once again, the business could be at risk, Gunderson tells investors in a research note. He believes, however, that a Pfizer divestment could bring some upside to ICU since the infusion pump business is not in the pharma giant's "wheelhouse." Gunderson keeps an Overweight rating on ICU Medical with a $129 price target.
10/07/16
ROTH
10/07/16
NO CHANGE
Target $160
ROTH
Buy
ICU Medical price target raised to $160 from $132 at Roth Capital
Roth Capital analyst Chris Lewis raised his price target for ICU Medical (ICUI) to $160 from $132 after the company announced an agreement to acquire Hospira Infusion Systems from Pfizer (PFE) for $1B. The analyst is overall positive on the deal as it removes the long-standing customer concentration overhang and grows ICU Medical into a legitimate pure-play infusion therapy company with a complete product portfolio. The company also preannounced Q3 preliminary results above expectations, he notes. Lewis reiterates a Buy rating on ICU Medical's shares.
08/09/16
ROTH
08/09/16
NO CHANGE
Target $132
ROTH
Buy
ICU Medical Direct sales momentum continues, says Roth Capital
Roth Capital analyst Chris Lewis says ICU Medical delivered a Q2 beat and raised its 2016 outlook as Direct sales momentum and OEM/Hospira growth continued. Although the company expects an even steeper decline in Hospira over the second half of 2016, the analyst believes ICU Medical is well-positioned to sustain revenue growth on Direct strength and non-Hospira OEM channels, with margin expansion opportunities materializing in 2017. Lewis reiterates a Buy rating on the stock and raised his price target on the shares to $132 from $130.
PFE Pfizer
$33.56

-0.09 (-0.27%)

09/14/16
BMOC
09/14/16
NO CHANGE
BMOC
Pfizer should exceed fiscal 2016 guidance, says BMO Capital
BMO Capital analyst Alex Arfaei says that Pfizer should exceed its fiscal 2016 guidance. The analyst says that Medivation, which Pfizer agreed to acquire, gives Pfizer another growth driver. Additionally, Pfizer has a number of other "high margin specialty drugs," according to the analyst. He says that the stock's dividend yield is "attractive," and he keeps a $40 price target and Outperform rating on the shares.
08/23/16
RHCO
08/23/16
DOWNGRADE
RHCO
Neutral
Medivation downgraded to Neutral from Buy at SunTrust
Medivation (MDVN) has agreed to be acquired by Pfizer (PFE) for $81.50 per share.
08/23/16
PIPR
08/23/16
NO CHANGE
PIPR
Pfizer acquisition 'a good fit strategically,' says Piper Jaffray
After Pfizer (PFE) agreed to buy Medivation (MDVN), Piper Jaffray analyst Richard Purkiss says that Pfizer has obtained Xtandi, "a blockbuster prostate cancer treatment," and "a close-to-market and late-stage pipeline." The analyst thinks that Xtandi's expansion to use in adjuvant prostate cancer could increase its sales by 65%-70%. He keeps a $54 price target and Overweight rating on Pfizer.
DRI Darden
$61.63

0.68 (1.12%)

07/26/16
STFL
07/26/16
DOWNGRADE
STFL
Sell
Darden downgraded to Sell from Hold at Stifel
Stifel analyst Paul Westra downgraded Darden based on the firm's belief that the U.S. economy will probably enter a recession within nine months. As a result, the firm now expects two year industrywide comps to come in at 0.5% in the first half of 2018, versus the consensus outlook of 1.75%, Westra stated. The analyst says that Darden's Olve Garden and Longhorn brands are already seeing weak demand, while the company lacks "brand agility" amid "fierce competition." Target $53.
08/22/16
ADAM
08/22/16
INITIATION
Target $74
ADAM
Buy
Darden initiated with a Buy at Canaccord
Canaccord analyst Lynne Collier initiated coverage on the Restaurant industry with an overall cautious outlook, saying that being selective is key. The analyst started coverage of Darden with a Buy rating and $74 price target, making it one of only four Buy rated stocks among fifteen that were initiated.
09/06/16
OPCO
09/06/16
NO CHANGE
Target $70
OPCO
Outperform
Darden at a 'misplaced discount' to peers, says Oppenheimer
Oppenheimer analyst Brian Bittner believes the market has presented another Darden buying opportunity, with stock valuation sitting at a "misplaced discount" to peers. Further, the analyst believes better in-store execution, improved off-premise business and elevated brand momentum can sustain sales trends above peers. Bittner also sees limited risk to upcoming Q1 results. He reiterates an Outperform rating and $70 price target on the shares.
10/05/16
OPCO
10/05/16
NO CHANGE
Target $70
OPCO
Outperform
Darden to outperform on any improving group sentiment, says Oppenheimer
Oppenheimer analyst Brian Bittner believes Darden's unique risk/reward and superior fundamentals position shares to "meaningfully outperform" on any improving sentiment toward the group. The analyst sees the business as healthy, and says sales trends have momentum/drivers for continued industry outperformance. Further, Bittner believes EPS estimates still contain upside and valuation is very attractive. He reiterates an Outperform rating and $70 price target on the shares.
STZ Constellation Brands
$168.84

-2.19 (-1.28%)

09/28/16
RBCM
09/28/16
NO CHANGE
RBCM
Constellation Brands removed from Focus List at RBC Capital
RBC Capital analyst Nik Modi, noting that Constellation Brands' stock is up 16% this year, thinks that the stock could pause in the near-term "around the company's results." He notes that analysts are already expecting the company to report beat and raise results. Modi keeps a $181 price target and Outperform rating on the shares, but he removed the stock from the firm's Focus List.
09/15/16
FBCO
09/15/16
INITIATION
Target $178
FBCO
Neutral
Constellation Brands initiated with a Neutral at Credit Suisse
Credit Suisse analyst Laurent Grandet initiated coverage on Constellation Brands with a Neutral and a $178 price target saying high expectations are built into shares.
09/15/16
FBCO
09/15/16
INITIATION
FBCO
Neutral
Constellation Brands initiated with a Neutral at Credit Suisse
09/16/16
09/16/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. GoPro (GPRO) initiated with a Buy at BofA/Merrill. 2. JetBlue (JBLU) initiated with an Outperform at Imperial Capital. 3. PepsiCo (PEP), Dr Pepper Snapple (DPS), and Monster Beverage (MNST) were initiated with an Outperform at Credit Suisse, while the firm initiated Boston Beer (SAM) with an Underperform. Credit Suisse also initiated Coca-Cola (KO) and Constellation Brands (STZ) with a Neutral. 4. lululemon (LULU) initiated with a Positive at Susquehanna. 5. Target (TGT) coverage assumed with a Neutral at Credit Suisse. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
MON Monsanto
$103.36

-0.14 (-0.14%)

09/21/16
09/21/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Monsanto (MON) upgraded to Overweight from Neutral at JPMorgan with analyst Jeffrey Zekauskas saying the risk in the shares is "less than what the market assumes." 2. Barclays (BCS) upgraded to Buy from Hold at HSBC citing the pending disposal of non-core businesses and resulting value creation. 3. Etsy (ETSY) upgraded to Buy from Neutral at Monness Crespi with the firm's analyst believing that Etsy shares can still move higher and sees a solid opportunity for upward revisions from improving conversion rates due to enhanced search and mobile functionality, expanding take rates, and advanced cross-boarder commerce capabilities with vendors. 4. Clovis (CLVS) upgraded to Outperform from Neutral at Credit Suisse with analyst Kennen MacKay saying the potential for a takeover "outweighs concerns surrounding patent life, limited experience in platinum resistant/refractory patients, and PARPi competition." 5. Jabil Circuit (JBL) upgraded to Buy from Neutral at UBS with analyst Steven Milunovich saying the company's cash flow is nearing an inflection amid an upturn in its Apple (AAPL) business. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/26/16
BERN
09/26/16
UPGRADE
BERN
Market Perform
Monsanto upgraded to Market Perform from Underperform at Bernstein
09/27/16
GSCO
09/27/16
UPGRADE
GSCO
Neutral
Monsanto upgraded to Neutral from Sell at Goldman
09/26/16
BERN
09/26/16
UPGRADE
BERN
Market Perform
Monsanto upgraded on acquisition at Bernstein
As noted earlier, Bernstein upgraded Monsanto (MON) to Market Perform from Underperform. Analyst Jonas Oxgaard upgraded the stock after Bayer (BAYRY) agreed to buy Monsanto. However, he warned that "it's too early to tell" whether regulators will approve the deal, and he says that the risk is "skewed to the downside in the near-term." He recommends that investors avoid the stock for 6-9 months. Target to $105 from $90.
MU Micron
$17.61

-0.12 (-0.68%)

10/05/16
EVER
10/05/16
NO CHANGE
Target $25
EVER
Buy
Micron guidance conservative, buy on weakness, says Evercore ISI
Evercore ISI analyst CJ Muse said Micron's guidance is conservative and continues to believe there will be a DRAM shortage situation in CY17 that will drive earnings power to $2-$3 including SBC. Muse recommends adding to Micron positions on weakness and reiterates his Buy rating and $25 price target.
10/05/16
COWN
10/05/16
NO CHANGE
Target $19
COWN
Outperform
Micron interesting on a pullback, says Cowen
Cowen analyst Timothy Arcuri said Micron's guidance was troubling but he still sees a positive bias as DRAM supply/demand remains the first order driver for the company and industry capital expenditure is still being diverted to 3D NAND. Arcuri believes the shares will be interesting on a pullback, but said it is hardly his favorite idea. Arcuri maintained his Outperform rating and $19 price target on Micron shares.
10/05/16
SUSQ
10/05/16
NO CHANGE
Target $21
SUSQ
Positive
Micron investors should focus on DRAM fundamentals, says Susquehanna
Susquehanna analyst Mehdi Hosseini noted Micron reported better than expected Q4 results driven by higher revenues. The analyst said the company guidance is below the buy-side expectation and he believes they are still challenged by converting planar to 3D NAND. Hosseini said Micron investors should focus on improving DRAM fundamentals as the better environment bodes well for the company's minority interest income and should help free cash flow. Hosseini reiterated his Buy rating and raised his price target to $21 from $20 on Micron shares.
10/05/16
STFL
10/05/16
NO CHANGE
Target $22
STFL
Buy
Micron only at start of up cycle, says Stifel
Stifel analyst Kevin Cassidy raised his price target for Micron Technology to $22 from $20, saying the company last night delivered a "solid beat" to his expectations and the consensus forecast. The company's non-GAAP EPS guidance "has some controversy" and may cause some weakness in the shares, added Cassidy. However, he would be a buyer on the weakness, citing his view that Micron's up cycle is only at its beginning. The firm keeps its Buy rating on Micron shares.
AZZ AZZ Inc.
$55.82

-2.49 (-4.27%)

10/12/15
SIDC
10/12/15
DOWNGRADE
Target $59
SIDC
Neutral
AZZ Inc. downgraded to Neutral from Buy at Sidoti
Sidoti downgraded AZZ Inc. to Neutral due to valuation and maintained its $59 price target.
01/11/16
01/11/16
DOWNGRADE

Hold
AZZ Inc. downgraded to Hold from Buy at BB&T
03/28/16
STFL
03/28/16
INITIATION
STFL
Hold
AZZ Inc. coverage resumed with a Hold at Stifel
01/11/16
01/11/16
DOWNGRADE

On The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: AGL Resources (GAS) downgraded to Underweight from Equal Weight at Barclays... AZZ Inc. (AZZ) downgraded to Hold from Buy at BB&T... Affymetrix (AFFX) downgraded to Neutral from Buy at Mizuho... American Eagle (AEO) downgraded to Market Perform from Outperform at Telsey Advisory... Arc Logistics (ARCX) downgraded to Equal Weight from Overweight at Barclays... Arctic Cat (ACAT) downgraded to Market Perform from Strong Buy at Raymond James... Artisan Partners (APAM) downgraded to Hold from Buy at Jefferies... Ashford Hospitality Prime (AHP) downgraded to Market Perform from Outperform at JMP Securities... Ashford Hospitality (AHT) downgraded to Market Perform from Outperform at JMP Securities... Atmos Energy (ATO) downgraded to Underweight from Equal Weight at Barclays... Atwood Oceanics (ATW) downgraded to Market Perform from Outperform at Cowen... Azure downgraded to Market Perform from Outperform at FBR Capital... Barracuda (CUDA) downgraded to In-Line from Outperform at Imperial Capital... Boston Beer (SAM) downgraded to Neutral from Buy at Nomura... Brunswick (BC) downgraded to Market Perform from Outperform at Raymond James... Cabot Oil & Gas (COG) downgraded to Equal Weight from Overweight at Barclays... CarMax (KMX) downgraded to Buy from Conviction Buy at Goldman... CenterPoint Energy (CNP) downgraded to Neutral from Buy at SunTrust... DiamondRock (DRH) downgraded to Market Perform from Outperform at JMP Securities... Diana Shipping (DSX) downgraded to Underweight from Equal Weight at Barclays... Dynagas LNG (DLNG) downgraded to Underweight from Equal Weight at Barclays... F5 Networks (FFIV) downgraded to Mixed from Positive at OTR Global... GasLog Partners (GLOP) downgraded to Equal Weight from Overweight at Barclays... Genomic Health (GHDX) downgraded to Neutral from Overweight at Piper Jaffray... Grainger (GWW) downgraded to Underweight from Equal Weight at Morgan Stanley... Green Plains Partners (GPP) downgraded to Equal Weight from Overweight at Barclays... Harley-Davidson (HOG) downgraded to Underperform from Market Perform at Raymond James... Hershey (HSY) downgraded to Neutral from Overweight at JPMorgan... Hornbeck Offshore (HOS) downgraded to Market Perform from Outperform at Cowen... Host Hotels (HST) downgraded to Market Perform from Outperform at JMP Securities... Hudson Pacific (HPP) downgraded to Neutral from Outperform at Credit Suisse... ITT Corp. (ITT) downgraded to Hold from Buy at Vertical Research... JP Energy (JPEP) downgraded to Equal Weight from Overweight at Barclays... JPMorgan (JPM) downgraded to Neutral from Buy at Goldman... Janus Capital (JNS) downgraded to Neutral from Buy at Goldman... KNOT Offshore Partners (KNOP) downgraded to Equal Weight from Overweight at Barclays... Liberty Global (LBTYA) downgraded to Equal Weight from Overweight at Morgan Stanley... LyondellBasell (LYB) downgraded to Underperform from Outperform at CLSA... M&T Bank (MTB) downgraded to Neutral from Buy at Goldman... Marsh & McLennan (MMC) downgraded to Neutral from Outperform at Credit Suisse... Mead Johnson (MJN) downgraded to Neutral from Overweight at JPMorgan... NGL Energy Partners (NGL) downgraded to Hold from Buy at Wunderlich... Noble Corp. (NE) downgraded to Market Perform from Outperform at Cowen... Oaktree Capital (OAK) downgraded to Buy from Conviction Buy at Goldman... PBF Logistics (PBFX) downgraded to Equal Weight from Overweight at Barclays... Plains All American (PAA) downgraded to Equal Weight from Overweight at Barclays... Prospect Capital (PSEC) downgraded to Underperform from Market Perform at Wells Fargo... Prudential plc (PUK) downgraded to Hold from Buy at Deutsche Bank... Rose Rock Midstream (RRMS) downgraded to Equal Weight from Overweight at Barclays... Seaspan (SSW) downgraded to Equal Weight from Overweight at Barclays... Southcross Energy Partners (SXE) downgraded to Neutral from Buy at Citi... Southwestern Energy (SWN) downgraded to Equal Weight from Overweight at Barclays... StealthGas (GASS) downgraded to Equal Weight from Overweight at Barclays... SunCoke Energy Partners (SXCP) downgraded to Underweight from Equal Weight at Barclays... Tallgrass Energy (TEP) downgraded to Equal Weight from Overweight at Barclays... Tidewater (TDW) downgraded to Market Perform from Outperform at Cowen... USA Compression (USAC) downgraded to Underweight from Equal Weight at Barclays... Under Armour (UA) cut to sell on apparel share losses at Morgan Stanley... VF Corp. (VFC) downgraded to Underweight, market share has peaked, says Morgan Stanley... WPX Energy (WPX) downgraded to Underweight from Equal Weight at Barclays... WebMD (WBMD) downgraded to Neutral from Buy at SunTrust... Williams-Sonoma (WSM) downgraded to Neutral from Outperform at Wedbush... WisdomTree (WETF) downgraded to Sell from Neutral at Goldman... XL Group (XL) downgraded to Neutral from Outperform at Credit Suisse.
ANGO AngioDynamics
$16.58

0.055 (0.33%)

04/08/16
PIPR
04/08/16
INITIATION
Target $12
PIPR
Neutral
AngioDynamics assumed with a Neutral at Piper Jaffray
Piper Jaffray analyst Brooks West assumed coverage of AngioDynamics with a Neutral rating and $12 price target. The company's investment is clouded in the near-term given the recent management changes, West tells investors in a research note following AngioDynamics' Q3 results.
04/05/16
ADAM
04/05/16
DOWNGRADE
ADAM
Hold
AngioDynamics downgraded to Hold from Buy at Canaccord
11/10/15
11/10/15
DOWNGRADE

On The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: AngioDynamics (ANGO) downgraded to Market Perform from Outperform at Raymond James... Arch Coal (ACI) downgraded to Neutral from Buy at Sterne Agee CRT... Autodesk (ADSK) downgraded to Equal Weight from Overweight at Morgan Stanley... Bitauto (BITA) downgraded to Underperform from Outperform at CLSA... Black Knight Financial (BKFS) downgraded to Neutral from Buy at Monness Crespi... CEVA (CEVA) downgraded to Hold from Buy at Wunderlich... CIRCOR (CIR) downgraded to Accumulate from Speculative Buy at Seaport Global... Compania Cervecerias (CCU) downgraded to Hold from Buy at Deutsche Bank... CyberArk (CYBR) downgraded to Neutral at BofA/Merrill... Dean Foods (DF) downgraded to Underperform from Neutral at Credit Suisse... Dollar General (DG) downgraded to Peer Perform from Outperform at Wolfe Research... Dr. Reddy's Labs (RDY) downgraded to Neutral from Buy at Citi... EnerSys (ENS) downgraded to Neutral from Buy at CL King... Ensco (ESV) downgraded to Sell from Neutral at Clarksons Platou... Evercore Partners (EVR) downgraded to Neutral from Positive at Susquehanna... Fidelity & Guaranty Life (FGL) downgraded to Neutral from Outperform at Macquarie... Foot Locker (FL) downgraded to Neutral from Buy at Buckingham... GulfMark Offshore (GLF) downgraded to Sector Perform from Outperform at Iberia... Jamba (JMBA) downgraded to Neutral from Buy at Dougherty... Jazz Pharmaceuticals (JAZZ) downgraded to Neutral from Buy at Mizuho... King Digital (KING) downgraded to Equal Weight from Overweight at Morgan Stanley... MRC Global (MRC) downgraded to Hold from Buy at Maxim... Plum Creek Timber (PCL) downgraded to Neutral from Overweight at JPMorgan... Popeyes (PLKI) downgraded to Neutral following checks at Longbow... Provident Financial (PFS) downgraded to Neutral from Overweight at Piper Jaffray... RigNet (RNET) downgraded to Neutral from Buy at Sidoti... SMART Technologies (SMT) downgraded to Underperformer from Sector Performer at CIBC... Sealed Air (SEE) downgraded to Neutral from Outperform at Macquarie... Tesco (TSCDY) downgraded to Hold from Buy at Deutsche Bank... Textura (TXTR) downgraded on guidance cut, investment profile change at Oppenheimer... WM Morrison (MRWSY) downgraded to Sell from Hold at Deutsche Bank... WidePoint (WYY) downgraded to Hold from Buy at Craig-Hallum.
11/10/15
11/10/15
DOWNGRADE

Market Perform
AngioDynamics downgraded to Market Perform from Outperform at Raymond James
As previously reported, Raymond James downgraded AngioDynamics to Market Perform from Outperform. Analyst Jayson Bedford said he is skeptical of the second half 2016 ramp implied by guidance and does not see a catalyst for near-term multiple expansion. Bedford does not see any quick fixes and struggles to fine a path leading to outperformance.
YUM Yum! Brands
$87.72

0.28 (0.32%)

09/29/16
OPCO
09/29/16
NO CHANGE
Target $97
OPCO
Outperform
Yum! Brands remains a favorite at Oppenheimer
Oppenheimer analyst Brian Bittner says Yum! Brands remains one of his "favorite Outperforms," despite its 23% year-to-date gain. The analyst raised his price target on the stock to $97 from $96, citing his updated sum-of-parts heading into the October 31 separation of the company's China business. Nonetheless, Bittner notes that this does not incorporate additional potential upside from an attractive G&A opportunity, potential for larger than expected capital returns post-separation at both entities, and continued earnings power restoration at Yum China. He reiterates an Outperform rating on the shares.
09/29/16
BERN
09/29/16
NO CHANGE
BERN
New Yum! poised to benefit from cost cutting, unit growth, says Bernstein
Bernstein analyst Sara Senatore says that New Yum! - the global franchisor of KFC, Pizza Hut, and Taco Bell which will trade separately from the current company's China assets following an upcoming spin off - should benefit from cost cutting and steady unit growth. New Yum! will be able to cut up to $140M+.of costs, and "steady unit growth" should "provide underlying support" for its revenue, she stated. The analyst keeps a $98 price target and Outperform rating on current, combined Yum!.
10/06/16
OPCO
10/06/16
NO CHANGE
Target $97
OPCO
Outperform
Oppenheimer would be aggressive buyer of Yum! Brands below $90
After Yum! Brands reported an in-line earnings quarter, Oppenheimer analyst Brian Bittner remains attracted to the shares ahead of several catalysts. The analyst would be an aggressive buyer of Yum! Brands below $90 per share. He reiterates an Outperform rating and $97 price target on the stock.
09/23/16
09/23/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Twitter (TWTR) downgraded to Underperform from Sector Perform by RBC analyst Mark Mahaney, who cut his price target to $14 from $17. The research firm's survey of more than 1,100 advertising professionals and their attitudes towards Facebook (FB), Google (GOOG), Twitter and other high-profile names showed that, despite marketing budgets continuing to shift online, interest in the microblog platform appears to be declining. Of note, Twitter shares have surged this morning after CNBC's David Faber reported that Twitter is moving closer to selling itself and has received expressions of interest in a possible sale, although no deal is imminent. 2. Yum! Brands (YUM) downgraded to Outperform from Top Pick by RBC Capital analyst David Palmer based on valuation. His price target on Yum shares remains $97. 3. Becton Dickinson (BDX) downgraded to Sell from Neutral by Citi analyst Amit Hazan, who thinks a cyclical U.S. slowdown will push the company's organic growth below expectations. The analyst, who also sees a diminishing impact on Becton's growth from emerging markets, cut his price target for the shares to $165 from $167. 4. NextEra Energy (NEE) downgraded to Hold from Buy by Deutsche Bank analyst Jonathan Arnold, as he sees limited near-term upside with the shares up 23% year-to-date. "Extraordinarily frosty commentary" from two of three PUCT commissioners yesterday regarding NextEra's Oncor deal indicates an uphill battle in getting it approved, Arnold tells investors. 5. AVANGRID (AGR) downgraded to Underweight from Neutral by JPMorgan analyst Christopher Turnure, who thinks both the company's growth guidance and consensus expectations "appear ambitious." He lowered his price target for the shares to $41 and $44 and notes he does not have confidence in AVANGRID's near-term growth. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
HON Honeywell
$106.94

-8.67 (-7.50%)

10/06/16
BARD
10/06/16
INITIATION
Target $135
BARD
Outperform
Honeywell initiated with an Outperform at Baird
Baird analyst Peter.Arment initiated Honeywell with an Outperform and a $135 price target.
10/07/16
JPMS
10/07/16
NO CHANGE
JPMS
Overweight
Honeywell selloff on guidance a buying opportunity, says JPMorgan
JPMorgan analyst C. Stephen Tusa recommends using the selloff in shares of Honeywell following the company's Q3 guidance cut as a buying opportunity. The analyst puts himself in the "not that bad in the grand scheme" camp and notes Honeywell has $25B in balance sheet capacity. Tusa has an Overweight rating on the shares.
10/07/16
BERN
10/07/16
NO CHANGE
BERN
Honeywell still has positive attributes, says Bernstein
After Honeywell lowered its guidance and announced restructuring plans, Bernstein analyst Steven Winoker said that macro conditions and margins/restructuring led to the disappointing news. However, the analyst says that there are still multiple reasons to be upbeat on the stock, including his belief that the company's EPS growth will exceed 8% next year, and what he sees as the company's high margins and large cash reserves. The analyst keeps a $135 price target and Outperform rating on the stock.
10/06/16
BARD
10/06/16
INITIATION
Target $135
BARD
Honeywell initiated with an Outperform at Baird
Baird analyst Peter.Arment initiated Honeywell with an Outperform and a $135 price target.

TODAY'S FREE FLY STORIES

JUNO

Juno Therapeutics

$20.43

0.53 (2.66%)

15:09
12/04/16
12/04
15:09
12/04/16
15:09
Conference/Events
Juno Therapeutics to host analyst and investor meeting »

Analyst and Investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATRA

Atara Biotherapeutics

$18.90

-0.3 (-1.56%)

15:04
12/04/16
12/04
15:04
12/04/16
15:04
Hot Stocks
Atara Biotherapeutics reports presentation of Phase 2 CMV-CTL data »

Atara Biotherapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JCI

Johnson Controls

$45.32

-0.41 (-0.90%)

15:03
12/04/16
12/04
15:03
12/04/16
15:03
Conference/Events
Johnson Controls to hold a meeting »

Strategic Review &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIIB

Biogen

$297.19

1.41 (0.48%)

14:59
12/04/16
12/04
14:59
12/04/16
14:59
Hot Stocks
Biogen reports data presentations on hemophilia treatments Eloctate, Alprolix »

Biogen and Swedish Orphan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNMSF

Genmab

14:58
12/04/16
12/04
14:58
12/04/16
14:58
Conference/Events
Genmab to hold data review meeting »

Management discusses data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOGL

Alphabet Class A

$764.46

0.13 (0.02%)

, GOOG

Alphabet

$750.50

2.58 (0.34%)

14:53
12/04/16
12/04
14:53
12/04/16
14:53
Hot Stocks
Alphabet subsidiary Verily launches utensil product »

Alphabet subsidiary…

GOOGL

Alphabet Class A

$764.46

0.13 (0.02%)

GOOG

Alphabet

$750.50

2.58 (0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Jan

KYN

Kayne Anderson

$19.52

0.07 (0.36%)

14:48
12/04/16
12/04
14:48
12/04/16
14:48
Hot Stocks
Kayne Anderson reports net assets $2.2B as of November 30 »

Reports net asset value…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KED

Kayne Anderson

$19.29

0.03 (0.16%)

14:47
12/04/16
12/04
14:47
12/04/16
14:47
Hot Stocks
Kayne Anderson reports net assets $205M as of November 30 »

Reports net asset value…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COH

Coach

$36.23

-0.05 (-0.14%)

, BURBY

Burberry

$18.08

0.265 (1.49%)

14:37
12/04/16
12/04
14:37
12/04/16
14:37
Periodicals
Burberry rejected multiple approaches from Coach, FT says »

Burberry (BURBY) rejected…

COH

Coach

$36.23

-0.05 (-0.14%)

BURBY

Burberry

$18.08

0.265 (1.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNCFF

UniCredit

$2.22

0.03 (1.37%)

, AMP

Ameriprise

$113.47

-1.57 (-1.36%)

14:31
12/04/16
12/04
14:31
12/04/16
14:31
Periodicals
UniCredit to sell asset manager to Amundi for over EUR 3B, FT says »

UniCredit (UNCFF) is set…

UNCFF

UniCredit

$2.22

0.03 (1.37%)

AMP

Ameriprise

$113.47

-1.57 (-1.36%)

FIG

Fortress

$5.10

-0.1 (-1.92%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

RXN

Rexnord

$20.27

-0.72 (-3.43%)

14:09
12/04/16
12/04
14:09
12/04/16
14:09
Hot Stocks
Trump targets Rexnord over Mexico relocation plans, says 'no more' »

President-elect Donald…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$38.61

-0.27 (-0.69%)

, TWX

Time Warner

$93.80

-0.34 (-0.36%)

13:57
12/04/16
12/04
13:57
12/04/16
13:57
Periodicals
DirecTV NOW unlikely to make money, Barron's says »

AT&T's (T)…

T

AT&T

$38.61

-0.27 (-0.69%)

TWX

Time Warner

$93.80

-0.34 (-0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 07

    Dec

  • 07

    Dec

ARCH

Arch Coal

$79.32

1.6 (2.06%)

13:27
12/04/16
12/04
13:27
12/04/16
13:27
Periodicals
Arch Coal could gain 75%, Barron's says »

Arch Coal, which emerged…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DE

Deere

$101.50

-1.2 (-1.17%)

13:12
12/04/16
12/04
13:12
12/04/16
13:12
Periodicals
Deere could keep climbing, Barron's says »

Deere stock recently…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JCP

J.C. Penney

$9.81

0.28 (2.94%)

, GME

GameStop

$24.27

-0.37 (-1.50%)

12:57
12/04/16
12/04
12:57
12/04/16
12:57
Periodicals
Corporate tax cut can't save all retailers, Barron's says »

Though President-elect…

JCP

J.C. Penney

$9.81

0.28 (2.94%)

GME

GameStop

$24.27

-0.37 (-1.50%)

AEO

American Eagle

$16.17

-0.57 (-3.41%)

TJX

TJX

$77.10

-0.57 (-0.73%)

FL

Foot Locker

$74.23

0.55 (0.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 09

    Jan

ELY

Callaway Golf

$11.68

-0.3 (-2.50%)

12:40
12/04/16
12/04
12:40
12/04/16
12:40
Periodicals
Callaway Golf investors should take profits, Barron's says »

It "looks like a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EVC

Entravision

12:36
12/04/16
12/04
12:36
12/04/16
12:36
Periodicals
Entravision shares could reach $9, Barron's says »

Hispanic-focused…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

GOOG

Alphabet

$750.50

2.58 (0.34%)

, GOOGL

Alphabet Class A

$764.46

0.13 (0.02%)

12:26
12/04/16
12/04
12:26
12/04/16
12:26
Periodicals
Barron's picks top ten stocks for 2017 »

Selecting its ten…

GOOG

Alphabet

$750.50

2.58 (0.34%)

GOOGL

Alphabet Class A

$764.46

0.13 (0.02%)

AAPL

Apple

$109.90

0.41 (0.37%)

C

Citi

$56.02

-1.25 (-2.18%)

DAL

Delta Air Lines

$48.31

0.54 (1.13%)

DTEGY

Deutsche Telekom

$15.65

0.14 (0.90%)

MRK

Merck

$61.13

0.37 (0.61%)

NVS

Novartis

$68.17

0.42 (0.62%)

TOL

Toll Brothers

$29.32

0.18 (0.62%)

UL

Unilever; also tag UN

$39.67

0.5 (1.28%)

UN

Unilever; also tag UL

$39.47

0.35 (0.89%)

DIS

Disney

$98.50

-0.44 (-0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 06

    Dec

  • 06

    Dec

  • 06

    Dec

  • 12

    Dec

  • 15

    Jan

  • 26

    Jan

  • 08

    Mar

  • 13

    Mar

GMED

Globus Medical

$21.89

0.12 (0.55%)

, TLN

Talen Energy

10:55
12/04/16
12/04
10:55
12/04/16
10:55
Hot Stocks
S&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices »

S&P Dow Jones Indices…

GMED

Globus Medical

$21.89

0.12 (0.55%)

TLN

Talen Energy

UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

IM

Ingram Micro

$38.88

1.31 (3.49%)

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FANG

Diamondback Energy

$108.14

-1.86 (-1.69%)

10:55
12/04/16
12/04
10:55
12/04/16
10:55
Syndicate
Breaking Syndicate news story on Diamondback Energy »

Diamondback Energy files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMRN

BioMarin

$82.21

-1.12 (-1.34%)

, ESALY

Eisai

$57.91

0.59 (1.03%)

04:55
12/04/16
12/04
04:55
12/04/16
04:55
Conference/Events
American Epilepsy Society to hold annual meeting »

70th Annual Meeting of…

BMRN

BioMarin

$82.21

-1.12 (-1.34%)

ESALY

Eisai

$57.91

0.59 (1.03%)

GWPH

GW Pharmaceuticals

$112.32

3.04 (2.78%)

IART

Integra LifeSciences

$75.78

-1.07 (-1.39%)

MDT

Medtronic

$72.01

0.13 (0.18%)

MNK

Mallinckrodt

$53.61

0.51 (0.96%)

NVTA

Invitae

$6.95

0.16 (2.36%)

SAGE

SAGE Therapeutics

$49.02

-0.23 (-0.47%)

WTKWY

Wolters Kluwer

$34.08

-0.39 (-1.13%)

ZGNX

Zogenix

$13.05

0.35 (2.76%)

ZYNE

Zynerba

$13.64

0.83 (6.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 06

    Dec

  • 07

    Dec

  • 12

    Dec

  • 14

    Dec

  • 28

    Jan

  • 27

    Apr

CELG

Celgene

$117.63

-1.24 (-1.04%)

04:55
12/04/16
12/04
04:55
12/04/16
04:55
Conference/Events
Celgene to hold an analyst and investor event »

Management holds an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

  • 06

    Dec

INCY

Incyte

$102.02

2.09 (2.09%)

, PFE

Pfizer

$31.63

0.17 (0.54%)

04:55
12/04/16
12/04
04:55
12/04/16
04:55
Conference/Events
Canaccord biotech analyst to hold a dinner meeting »

In conjunction with the…

INCY

Incyte

$102.02

2.09 (2.09%)

PFE

Pfizer

$31.63

0.17 (0.54%)

LLY

Eli Lilly

$67.71

1.74 (2.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

  • 06

    Dec

  • 15

    Dec

JUNO

Juno Therapeutics

$20.43

0.53 (2.66%)

, KITE

Kite Pharma

$50.76

0.04 (0.08%)

21:25
12/03/16
12/03
21:25
12/03/16
21:25
Conference/Events
Canaccord biotech analyst to hold a dinner meeting »

In conjunction with the…

JUNO

Juno Therapeutics

$20.43

0.53 (2.66%)

KITE

Kite Pharma

$50.76

0.04 (0.08%)

BLUE

bluebird bio

$69.75

1.1 (1.60%)

NVS

Novartis

$68.17

0.42 (0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

  • 03

    Dec

  • 06

    Dec

09:15
12/03/16
12/03
09:15
12/03/16
09:15
General news
Breaking General news story  »

New York Federal Reserve…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.